Tricyclohexylphosphonium Tetrafluoroborate acts as a reagent in the synthesis of potent JAK2 inhibitor BMS-911543 as a potential treatment for myeloproliferative disorders, preparation of Lapatinib intermediate via arylation of furfural with bromochlorofluorobenzyloxyphenylquinazolinamine, structure-activity relationships of carboline and carbazole derivatives as ATP-competitive kinesin spindle protein inhibitors.
參考文獻
Fitzgerald, M. A., et al.: J. Org. Chem., 80, 6001 (2015); Erickson, G., et al.: Tetrahedron Lett., 55, 6007 (2014); Takeuchi, T., et al.: J. Med. Chem., 54, 4839 (2011)
滬ICP備17019645號
400-821-0725
